Maternal and neonatal outcomes after gonadotropin-releasing hormone agonist trigger for final oocyte maturation in patients undergoing in vitro fertilization

Fertility and Sterility

Volumn 102, Issue 3, 2014, Pages 753-758

  Budinetz, Tara H ^a   Mann, Jessica S ^a   Griffin, Daniel W ^a   Benadiva, Claudio A ^a   Nulsen, John C ^a   Engmann, Lawrence L ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

congenital anomalies; GnRH agonist; IVF; OHSS; pregnancy outcomes

Indexed keywords

CHORIONIC GONADOTROPIN; GONADORELIN AGONIST; LEUPRORELIN;

ADULT; ARTICLE; CHORIOAMNIONITIS; CONGENITAL MALFORMATION; CONTROLLED STUDY; DELIVERY; FEMALE; FERTILIZATION IN VITRO; GESTATION PERIOD; HUMAN; MAJOR CLINICAL STUDY; NEWBORN DISEASE; OOCYTE MATURATION; OVARY HYPERSTIMULATION; PLACENTA ACCRETA; PLACENTA PREVIA; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; SOLUTIO PLACENTAE;

CONGENITAL ANOMALIES; GNRH AGONIST; IVF; OHSS; PREGNANCY OUTCOMES;

ADULT; CHORIONIC GONADOTROPIN; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFANT, NEWBORN; MALE; MENOTROPINS; OOCYTES; OOGENESIS; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 84906938027     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2014.05.030     Document Type: Article

References (44)

1. A. Delvigne, and S. Rozenberg Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS) Hum Reprod Update 9 2003 77 96
2. L. Engmann, A. DiLuigi, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study Fertil Steril 89 2008 84 91
3. P. Humaidan, S. Kol, and E.G. Papanikolaou GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum Reprod Update 17 2011 510 524
4. S. Kol Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome Fertil Steril 81 2004 1 5
5. J. Wen, J. Jiang, C. Ding, J. Dai, Y. Liu, and Y. Xia et al. Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a meta-analysis Fertil Steril 97 2012 1331 1337.e1-4
6. M.J. Davies, V.M. Moore, K.J. Willson, P. Van Essen, K. Priest, and H. Scott et al. Reproductive technologies and the risk of birth defects N Engl J Med 366 2012 1803 1813
7. S. Pandey, A. Shetty, M. Hamilton, S. Bhattacharya, and A. Maheshwari Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF/ICSI: a systematic review and meta-analysis Hum Reprod Update 18 2012 485 503
8. S. Koivurova, A.L. Hartikainen, M. Gissler, E. Hemminki, U. Sovio, and M.R. Jarvelin Neonatal outcome and congenital malformations in children born after in-vitro fertilization Hum Reprod 17 2002 1391 1398
9. F.M. Helmerhorst, D.A. Perquin, D. Donker, and M.J. Keirse Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies Br Med J 328 2004 261
10. R.A. Jackson, K.A. Gibson, Y.W. Wu, and M.S. Croughan Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis Obstet Gynecol 103 2004 551 563
11. U.M. Reddy, R.J. Wapner, R.W. Rebar, and R.J. Tasca Infertility, assisted reproductive technology, and adverse pregnancy outcomes: executive summary of a National Institute of Child Health and Human Development workshop Obstet Gynecol 109 2007 967 977
12. The Practice Committee of the Society for Assisted Reproductive Technology and American Society for Reproductive Medicine Guidelines on number of embryos transferred Fertil Steril 90 2008 S163 S164
13. K. Marquard, and K. Moley Multiple gestations and assisted reproductive technology C.G. Gleason, S.U. Devaskar, Avery's diseases of the newborn 9th ed 2012 Elsevier Philadelphia 60 66
14. J.L. Zhu, O. Basso, C. Obel, C. Bille, and J. Olsen Infertility, infertility treatment, and congenital malformations: Danish national birth cohort Br Med J 333 2006 679
15. L.B. Romundstad, P.R. Romundstad, A. Sunde, V. von During, R. Skjaerven, and D. Gunnell et al. Effects of technology or maternal factors on perinatal outcome after assisted fertilisation: a population-based cohort study Lancet 372 2008 737 743
16. A.M. Jaques, D.J. Amor, H.W. Baker, D.L. Healy, O.C. Ukoumunne, and S. Breheny et al. Adverse obstetric and perinatal outcomes in subfertile women conceiving without assisted reproductive technologies Fertil Steril 94 2010 2674 2679
17. M. Hayashi, A. Nakai, S. Satoh, and Y. Matsuda Adverse obstetric and perinatal outcomes of singleton pregnancies may be related to maternal factors associated with infertility rather than the type of assisted reproductive technology procedure used Fertil Steril 98 2012 922 928
18. P.J. Boerrigter, J.J. de Bie, B.M. Mannaerts, B.P. van Leeuwen, and D.P. Passier-Timmermans Obstetrical and neonatal outcome after controlled ovarian stimulation for IVF using the GnRH antagonist ganirelix Hum Reprod 17 2002 2027 2034
19. M. Bonduelle, J. Oberye, B. Mannaerts, and P. Devroey Large prospective, pregnancy and infant follow-up trial assures the health of 1000 fetuses conceived after treatment with the GnRH antagonist ganirelix during controlled ovarian stimulation Hum Reprod 25 2010 1433 1440
20. M. Hansen, C. Bower, E. Milne, N. de Klerk, and J.J. Kurinczuk Assisted reproductive technologies and the risk of birth defects - a systematic review Hum Reprod 20 2005 328 338
21. A. Bermejo, M. Cerrillo, M. Ruiz-Alonso, D. Blesa, C. Simon, and A. Pellicer et al. Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression Fertil Steril 101 2014 138 146.e3
22. P. Humaidan, H.E. Bredkjaer, L. Bungum, M. Bungum, M.L. Grondahl, and L. Westergaard et al. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study Hum Reprod 20 2005 1213 1220
23. E.M. Kolibianakis, A. Schultze-Mosgau, A. Schroer, A. van Steirteghem, P. Devroey, and K. Diedrich et al. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists Hum Reprod 20 2005 2887 2892
24. E.G. Papanikolaou, C. Pozzobon, E.M. Kolibianakis, M. Camus, H. Tournaye, and H.M. Fatemi et al. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles Fertil Steril 85 2006 112 120
25. M. Bonduelle, I. Liebaers, V. Deketelaere, M.P. Derde, M. Camus, and P. Devroey et al. Neonatal data on a cohort of 2889 infants born after ICSI (1991-1999) and of 2995 infants born after IVF (1983-1999) Hum Reprod 17 2002 671 694
26. J.M. Aase Diagnostic dysmorphology 1990 Plenum Press New York
27. E.B. Johnston-MacAnanny, A.J. DiLuigi, L.L. Engmann, D.B. Maier, C.A. Benadiva, and J.C. Nulsen Selection of first in vitro fertilization cycle stimulation protocol for good prognosis patients: gonadotropin releasing hormone antagonist versus agonist protocols J Reprod Med 56 2011 12 16
28. V. Vlaisavljevic, M. Reljic, V.G. Lovrec, and B. Kovacic Comparable effectiveness using flexible single-dose GnRH antagonist (cetrorelix) and single-dose long GnRH agonist (goserelin) protocol for IVF cycles - a prospective, randomized study Reprod Biomed Online 7 2003 301 308
29. Q. Lai, H. Zhang, G. Zhu, Y. Li, L. Jin, and L. He et al. Comparison of the GnRH agonist and antagonist protocol on the same patients in assisted reproduction during controlled ovarian stimulation cycles Int J Clin Exp Pathol 6 2013 1903 1910
30. D. Bodri, S.K. Sunkara, and A. Coomarasamy Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors: a systematic review and meta-analysis Fertil Steril 95 2011 164 169
31. H.G. Al-Inany, M.A. Youssef, M. Aboulghar, F. Broekmans, M. Sterrenburg, and J. Smit et al. GnRH antagonists are safer than agonists: an update of a Cochrane review Hum Reprod Update 17 2011 435
32. H.G. Al-Inany, M.A. Youssef, M. Aboulghar, F. Broekmans, M. Sterrenburg, and J. Smit et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology Cochrane Database Syst Rev 2011 CD001750
33. A.J. DiLuigi, L. Engmann, D.W. Schmidt, D.B. Maier, J.C. Nulsen, and C.A. Benadiva Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting Fertil Steril 94 2010 1111 1114
34. L. Engmann, and C. Benadiva Ovarian hyperstimulation syndrome prevention strategies: luteal support strategies to optimize pregnancy success in cycles with gonadotropin-releasing hormone agonist ovulatory trigger Semin Reprod Med 28 2010 506 512
35. B. Acevedo, J.L. Gomez-Palomares, E. Ricciarelli, and E.R. Hernandez Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates Fertil Steril 86 2006 1682 1687
36. L. Engmann, and C. Benadiva Agonist trigger: what is the best approach? Agonist trigger with aggressive luteal support Fertil Steril 97 2012 531 533
37. A.C. Enders Trophoblast-uterine interactions in the first days of implantation: models for the study of implantation events in the human Semin Reprod Med 18 2000 255 263
38. E.R. Norwitz, D.J. Schust, and S.J. Fisher Implantation and the survival of early pregnancy N Engl J Med 345 2001 1400 1408
39. J.W. Meekins, R. Pijnenborg, M. Hanssens, I.R. McFadyen, and A. van Asshe A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies Br J Obstet Gynaecol 101 1994 669 674
40. R.B. Ness, and B.M. Sibai Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia Am J Obstet Gynecol 195 2006 40 49
41. A.Z. Isik, G.S. Caglar, E. Sozen, C. Akarsu, G. Tuncay, and T. Ozbicer et al. Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study Reprod Biomed Online 19 2009 472 477
42. J. Tesarik, A. Hazout, and C. Mendoza Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation Hum Reprod 19 2004 1176 1180
43. P. Mastroiacovo, E.E. Castilla, C. Arpino, B. Botting, G. Cocchi, and J. Goujard et al. Congenital malformations in twins: an international study Am J Med Genet 83 1999 117 124
44. S.V. Glinianaia, J. Rankin, and C. Wright Congenital anomalies in twins: a register-based study Hum Reprod 23 2008 1306 1311